Purdue Pharma and the Sackler Family Reach New $7.4 Billion Opioid Settlement
Purdue Pharma and the Sackler family have recently reached a $7.4 billion settlement in principle to resolve thousands of lawsuits alleging that OxyContin propelled a widespread opioid addiction crisis in the United States.
As part of the bankruptcy case, seven Sacklers — all former Purdue board members or employees — were deposed in 2020. Dr. Richard Sackler, a former Purdue president, in 2001 helped turn ...
Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a bankruptcy case.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback